Scarica l'app Stockscreener
7.73
1.65%
-0.13
Dopo l'orario di chiusura:
7.71
-0.02
-0.26%
Precedente Chiudi:
$7.86
Aprire:
$7.77
Volume 24 ore:
273.25K
Relative Volume:
1.82
Capitalizzazione di mercato:
$161.51M
Reddito:
-
Utile/perdita netta:
$-22.38M
Rapporto P/E:
-5.4823
EPS:
-1.41
Flusso di cassa netto:
$-15.54M
1 W Prestazione:
-2.77%
1M Prestazione:
-3.13%
6M Prestazione:
+18.02%
1 anno Prestazione:
+11.22%
Intervallo 1D:
$7.67
$8.11
Intervallo di 1 settimana:
$7.67
$8.21
Portata 52W:
$4.44
$11.80
Nuvectis Pharma Inc Stock (NVCT) Company Profile
Nome
Nuvectis Pharma Inc
Settore
Industria
Telefono
360-837-7232
Indirizzo
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Confronta NVCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVCT
Nuvectis Pharma Inc
|
7.73 | 164.22M | 0 | -22.38M | -15.54M | -1.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-02 | Iniziato | Maxim Group | Buy |
| 2025-03-17 | Iniziato | Laidlaw | Buy |
| 2022-07-13 | Iniziato | Ladenburg Thalmann | Buy |
Nuvectis Pharma Inc Borsa (NVCT) Ultime notizie
What drives Nuvectis Pharma Inc. stock priceRecord-breaking capital gains - Autocar Professional
Why Nuvectis Pharma Inc. stock is on top investor watchlistsExplosive capital appreciation - jammulinksnews.com
Nuvectis Pharma Inc. Stock Analysis and ForecastHigh-yield investments - Autocar Professional
What analysts say about Nuvectis Pharma Inc. stockDynamic profit opportunities - Autocar Professional
Is Nuvectis Pharma Inc. a good long term investmentTremendous wealth creation - jammulinksnews.com
(NVCT) On The My Stocks Page - news.stocktradersdaily.com
Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - Yahoo.co
How Nuvectis Pharma Inc. stock performs during market volatilityFree Growth Investment Group - Newser
What makes Nuvectis Pharma Inc. stock price move sharplyHigh Confidence Trade Setups - Newser
Why Nuvectis Pharma Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser
When (NVCT) Moves Investors should Listen - news.stocktradersdaily.com
Nuvectis reports positive drug interaction study for cancer drug NXP900 By Investing.com - Investing.com Nigeria
Nuvectis Pharma, Inc. Announces Successful Completion of A Drug-Drug Interaction Study in Healthy Volunteers - MarketScreener
Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies - GlobeNewswire
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Purchased by Oppenheimer & Co. Inc. - Defense World
(NVCT) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Nuvectis Pharma, Inc.(NasdaqCM: NVCT) added to Russell 3000 Index - MarketScreener
Nuvectis Pharma (NASDAQ:NVCT) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Is Nuvectis Pharma, Inc. technically bullish or bearish? - MarketsMojo
(NVCT) Proactive Strategies - news.stocktradersdaily.com
Silicon Valley - FinancialContent
Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In - Seeking Alpha
Insiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchases - Yahoo Finance
Insider Stock Buying Of Nuvectis Pharma Delivers Return On US$2.19m Investment - simplywall.st
Nuvectis Pharma Approves Proposals at Annual Meeting - TipRanks
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Sold by Two Sigma Investments LP - Defense World
Millennium Management LLC Reduces Holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World
(NVCT) Investment Analysis - news.stocktradersdaily.com
Squarepoint Ops LLC Invests $103,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World
Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect? - MSN
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Bought by Northern Trust Corp - Defense World
Cubist Systematic Strategies LLC Invests $34,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World
Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference - GlobeNewswire
Nuvectis Pharma Inc Azioni (NVCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):